News

All news

CSR Events General PERSONAL CARE Press release Products & Technologies Protéus

CELLforCURE launches a process to find a buyer for its Les Ulis site

CELLforCURE, a subsidiary of the SEQENS Group, has informed its employee representatives of its decision to look for a potential buyer for its site in Les Ulis (Essonne). CELLforCURE specializes in the development and the contract manufacturing of Cell & Gene therapies.

Update on isopropanol plant expansion

SK Capital becomes the new majority shareholder of Seqens – Q&A

Seqens becomes a partner of the RoLA-FLEX project

Formic Acid Recovery for ChemoxyCare range

Seqens Prize of the French Académie des Sciences 2021

SEQENS unveils its new pharmaceutical quality control laboratory in the presence of Jean Castex, French Prime Minister.

Eurazeo announces that it has entered into exclusive discussions to sell its stake in SEQENS

Labcom HitCat Inauguration in partnership with the CNRS

France Relance program: SEQENS new paracetamol production unit

Seqens is proud to announce the official partnership between Alganelle and Sederma for the development of a future cosmetic ingredient.

Protéus by Seqens, expertise partner of the virtual congress Protein Engineering Connect

Seqens supports the French Business Climate Pledge initiative

1 2 3 4 5 6 7

Contact